Showing results (41-50 of 228) with videos related to
Sort By:
Pageof 23
BMJ Open|September 28, 2022
How do care environments shape healthcare? A synthesis of qualitative studies among healthcare workers during the COVID-19 pandemicMia Harrison, Tim Rhodes, Kari LancasterHealth (London, England : 1997)|January 28, 2021
Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limitsJake Rance, Tim Rhodes, Kari LancasterBMJ Global Health|February 27, 2024
In search of a 'good number': knowledge controversy and population estimates in the endgame of hepatitis C eliminationTim Rhodes, Kari Lancaster, Sophie AdamsThe International Journal on Drug Policy|April 13, 2019
"Towards eliminating viral hepatitis": Examining the productive capacity and constitutive effects of global policy on hepatitis C eliminationKari Lancaster, Tim Rhodes, Jake RanceThe International Journal on Drug Policy|November 26, 2016
A critical examination of the definition of 'psychoactive effect' in Australian drug legislationMonica J Barratt, Kate Seear, Kari LancasterThe International Journal on Drug Policy|June 25, 2011
How do Australian news media depict illicit drug issues? An analysis of print media reporting across and between illicit drugs, 2003-2008Caitlin Elizabeth Hughes, Kari Lancaster, Bridget SpicerSociology of Health & Illness|March 3, 2019
Making the subjects of mental health care: a cross-cultural comparison of mental health policy in Hong Kong, China and New South Wales, AustraliaJialiang Cui, Kari Lancaster, Christy E NewmanDrug and Alcohol Dependence|December 15, 2012
The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent peopleSarah Larney, Deborah Randall, Amy Gibson, et al.Drug and Alcohol Review|June 22, 2016
A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, AustraliaSarah Larney, Deborah Zador, Natasha Sindicich, et al.The International Journal on Drug Policy|July 29, 2021
Mapping drug epidemiology futuresSarah Larney, Hannah Jones, Tim Rhodes, et al.Pageof 23